Kommineni, V.; Markert, M.; Ren, Z.; Palle, S.; Carrillo, B.; Deng, J.; Tejeda, A.; Nandi, S.; McDonald, K.A.; Marcel, S.;
et al. In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in Nicotiana benthamiana Plants. Int. J. Mol. Sci. 2019, 20, 194.
https://doi.org/10.3390/ijms20010194
AMA Style
Kommineni V, Markert M, Ren Z, Palle S, Carrillo B, Deng J, Tejeda A, Nandi S, McDonald KA, Marcel S,
et al. In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in Nicotiana benthamiana Plants. International Journal of Molecular Sciences. 2019; 20(1):194.
https://doi.org/10.3390/ijms20010194
Chicago/Turabian Style
Kommineni, Vally, Matthew Markert, Zhongjie Ren, Sreenath Palle, Berenice Carrillo, Jasmine Deng, Armando Tejeda, Somen Nandi, Karen A. McDonald, Sylvain Marcel,
and et al. 2019. "In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in Nicotiana benthamiana Plants" International Journal of Molecular Sciences 20, no. 1: 194.
https://doi.org/10.3390/ijms20010194
APA Style
Kommineni, V., Markert, M., Ren, Z., Palle, S., Carrillo, B., Deng, J., Tejeda, A., Nandi, S., McDonald, K. A., Marcel, S., & Holtz, B.
(2019). In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in Nicotiana benthamiana Plants. International Journal of Molecular Sciences, 20(1), 194.
https://doi.org/10.3390/ijms20010194